243 related articles for article (PubMed ID: 12006992)
1. [hEPO transfer and expression by a recombinant adeno-associated virus vector].
Wu ZJ; Wu XB; Wang H; Lu B; Dong XY; Hou YD
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar; 34(2):176-80. PubMed ID: 12006992
[TBL] [Abstract][Full Text] [Related]
2. Adeno-associated virus mediated expression of human erythropoietin in vitro.
Diao Y; Xu RA; Wang GJ; Zhao XC
Acta Pharmacol Sin; 2002 Jan; 23(1):55-8. PubMed ID: 11860738
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus-mediated delivery of erythropoietin leads to sustained elevation of hematocrit in nonhuman primates.
Zhou S; Murphy JE; Escobedo JA; Dwarki VJ
Gene Ther; 1998 May; 5(5):665-70. PubMed ID: 9797871
[TBL] [Abstract][Full Text] [Related]
4. Practical considerations of recombinant adeno-associated virus-mediated gene transfer for treatment of retinal degenerations.
Shen WY; Lai CM; Lai YK; Zhang D; Zaknich T; Sutanto EN; Constable IJ; Rakoczy PE
J Gene Med; 2003 Jul; 5(7):576-87. PubMed ID: 12825197
[TBL] [Abstract][Full Text] [Related]
5. Salivary glands as a potential gene transfer target for gene therapeutics of some monogenetic endocrine disorders.
Voutetakis A; Bossis I; Kok MR; Zhang W; Wang J; Cotrim AP; Zheng C; Chiorini JA; Nieman LK; Baum BJ
J Endocrinol; 2005 Jun; 185(3):363-72. PubMed ID: 15930162
[TBL] [Abstract][Full Text] [Related]
6. Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids.
Booth MJ; Mistry A; Li X; Thrasher A; Coffin RS
Gene Ther; 2004 May; 11(10):829-37. PubMed ID: 14985784
[TBL] [Abstract][Full Text] [Related]
7. [Construction of a hepatoma-targeting vector of adeno-associated virus containing human alpha-fetoprotein promoter and wild p53 gene in gene therapy of liver cancer].
Cheng J; Leng X; Peng J
Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):461-3. PubMed ID: 11798803
[TBL] [Abstract][Full Text] [Related]
8. Generation of recombinant adeno-associated virus vectors by a complete adenovirus-mediated approach.
Zhang X; Li CY
Mol Ther; 2001 May; 3(5 Pt 1):787-92. PubMed ID: 11356083
[TBL] [Abstract][Full Text] [Related]
9. Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis.
McCarty DM; Monahan PE; Samulski RJ
Gene Ther; 2001 Aug; 8(16):1248-54. PubMed ID: 11509958
[TBL] [Abstract][Full Text] [Related]
10. Scaleable chromatographic purification process for recombinant adeno-associated virus (rAAV).
O'Riordan CR; Lachapelle AL; Vincent KA; Wadsworth SC
J Gene Med; 2000; 2(6):444-54. PubMed ID: 11199265
[TBL] [Abstract][Full Text] [Related]
11. Transfer of the feline erythropoietin gene to cats using a recombinant adeno-associated virus vector.
Beall CJ; Phipps AJ; Mathes LE; Stromberg P; Johnson PR
Gene Ther; 2000 Mar; 7(6):534-9. PubMed ID: 10757028
[TBL] [Abstract][Full Text] [Related]
12. Dose response to a single intramuscular injection of recombinant adeno-associated virus-erythropoietin in monkeys.
Rudich SM; Zhou S; Srivastava R; Escobedo JA; Perez RV; Manning WC
J Surg Res; 2000 May; 90(2):102-8. PubMed ID: 10792948
[TBL] [Abstract][Full Text] [Related]
13. Effect of polyethylenimine on recombinant adeno-associated virus mediated insulin gene therapy.
Hsu PY; Yang YW
J Gene Med; 2005 Oct; 7(10):1311-21. PubMed ID: 15906397
[TBL] [Abstract][Full Text] [Related]
14. An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes.
Kang W; Wang L; Harrell H; Liu J; Thomas DL; Mayfield TL; Scotti MM; Ye GJ; Veres G; Knop DR
Gene Ther; 2009 Feb; 16(2):229-39. PubMed ID: 18923452
[TBL] [Abstract][Full Text] [Related]
15. Efficient gene transfer into human keratinocytes with recombinant adeno-associated virus vectors.
Braun-Falco M; Doenecke A; Smola H; Hallek M
Gene Ther; 1999 Mar; 6(3):432-41. PubMed ID: 10435093
[TBL] [Abstract][Full Text] [Related]
16. Longevity of rAAV vector and plasmid DNA in blood after intramuscular injection in nonhuman primates: implications for gene doping.
Ni W; Le Guiner C; Gernoux G; Penaud-Budloo M; Moullier P; Snyder RO
Gene Ther; 2011 Jul; 18(7):709-18. PubMed ID: 21390073
[TBL] [Abstract][Full Text] [Related]
17. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus.
Liu XL; Clark KR; Johnson PR
Gene Ther; 1999 Feb; 6(2):293-9. PubMed ID: 10435114
[TBL] [Abstract][Full Text] [Related]
18. Optimised helper virus-free production of high-quality adeno-associated virus vectors.
Drittanti L; Jenny C; Poulard K; Samba A; Manceau P; Soria N; Vincent N; Danos O; Vega M
J Gene Med; 2001; 3(1):59-71. PubMed ID: 11269337
[TBL] [Abstract][Full Text] [Related]
19. Regulation of gene expression in vivo following transduction by two separate rAAV vectors.
Rendahl KG; Leff SE; Otten GR; Spratt SK; Bohl D; Van Roey M; Donahue BA; Cohen LK; Mandel RJ; Danos O; Snyder RO
Nat Biotechnol; 1998 Aug; 16(8):757-61. PubMed ID: 9702775
[TBL] [Abstract][Full Text] [Related]
20. Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer.
Isayeva T; Ren C; Ponnazhagan S
Clin Cancer Res; 2005 Feb; 11(3):1342-7. PubMed ID: 15709207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
